Cardiac Regeneration

Cardiac Regeneration seeks to treat irreversibly damaged heart tissue with cutting-edge knowledge and stem cell therapy. The mortal heart has extremely limited regenerative capacity, making regeneration a difficult job. Cardiomyocytes in the adult mortal heart turn over at a low rate, thought to be 0.5 - 1 every time. The most prevalent cardiovascular complaint is myocardial infarction (MI). An average-sized MI results in the loss of over one billion cardiomyocytes, which the adult heart is unable to replenish. Using the body's natural ability to regenerate itself, colourful strategies have been devised to restore the damaged heart towel and its function. Cardiology procedures are attempting to restore, renew, and reclaim cases that have regenerate ability to recoup themselves.


  • Angiogenesis
  • Cardio myocyte proliferation
  • Cardiac regenerative therapy
  • Transcription
  • Tissue engineering

Related Conference of Cardiac Regeneration

May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland
October 30-31, 2024

7th Global Cardiovascular Research and Clinical Cardiology

Vancouver, Canada

Cardiac Regeneration Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in